Celgene Sues Dr. Reddy's To Block Cancer Drug Generic
Celgene has hit Dr. Reddy's Laboratories with a lawsuit in New Jersey federal court seeking to block the Indian drugmaker from marketing generic versions of the Bristol-Myers Squibb unit's blockbuster cancer...To view the full article, register now.
Already a subscriber? Click here to view full article